Senolytic protocol (fisetin/quercetin)

Senolytic protocols using fisetin and quercetin are dietary supplements that target aging cells to potentially slow down age-related diseases. Studies have found that these compounds can reduce senescent cells, which secrete harmful substances linked to conditions like atherosclerosis and glioma recurrence. By targeting the senescence-associated secretory phenotype, these protocols may help mitigate inflammation and tissue damage associated with aging. Connections to cardiovascular health and cancer prevention suggest potential broad benefits from using fisetin and quercetin in anti-aging strategies. However, more research is needed to fully understand their long-term effects and optimal usage.

Sources

• Pharmacological targeting of the senescence-associated secretory phenotype in atherosclerosis: therapeutic potential of senolytics and senomorphics. (PMID:42133066)
• The Emerging Role of Senolytics as a Next-Generation Strategy Against Glioma Recurrence: A Narrative Review. (PMID:42073546)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._